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Chain Reaction (RT-snPCR) assay described by Nix and colleagues (Nix et al., 2006) for direct 1 0 8
(cell culture independent) detection of enteroviruses from clinical specimen (WHO, 2015) . The Nix (subsequently referred to in this study as Species Resolution Primers) in the second round PCR of 1 2 1 the WHO recommended RT-snPCR assay the resolving power of the assay could be improved. However, in a polio-free world, that there might be reduced funding for enterovirus surveillance, RT-snPCR assay by inclusion of three poliovirus-specific forward primers in the second round 1 2 6 assay, thus, making it possible to independently detect the three poliovirus types even in cases of 1 2 7 co-infection. used as reference samples in this study and analyzed as depicted in the study algorithm ( Figure 1 ).
5 2
Isolation and characterization of samples 1 through 12 have been previously described (Faleye and Surveillance (ES) laboratory in Ibadan, Nigeria and provided to us as references for Sabin 1 and 3 All primers were re-constituted in concentrations of 100μM and first round PCR was done in The second round PCR was done in 30μL reactions. It contained 0.3μL each of forward and RNase free water. As shown in the algorithm (Figure 1 ), six different second round PCR assays 1 7 7
Seminested Polymerase Chain Reaction (snPCR) Assay for Enterovirus VP1 gene
were done using the first round PCR product as template. Hence, all six second round PCR assays 1 7 8
used different forward primers (Table 2) All amplicons generated from the six second round PCR assays were shipped to Macrogen Inc, The accession numbers for the newly described sequence data generated in this study are 1 9 1 KX856914-KX856921. For isolates one to eight which were previously known to be EV-Bs, primer AN89, amplified only 1 9 7 six of the eight samples (Table 1) . It is noteworthy that the two isolates not amplified by primer 1 9 8
AN89 were previously identified as E19. Also, the only previously identified E19 (sample 2) 1 9 9
subsequently amplified by primer AN89 in this study was identified as E7 (Table 1) . Further, the 2 0 0 identity of the previously unidentified (sample 8) was shown to be E7, and all the other previously 2 0 1
identified E7s and the E3 were confirmed (Table 1) . did not amplify any of the isolates in samples 1 to 8 (Table 1 ).
0 9
For isolates nine to twelve which were all previously identified as CV-A13 (EV-C) (Faleye and The SRPs also confirmed all as such. However, it is worth mentioning that primers 189 and 187 2 1 2 could not confirm samples 9 and 11 respectively because the sequence data were unexploitable. The PRPs did not amplify any of the isolates in samples 9 to 12 (Table 1) .
1 4
For isolates 13 to 15 (previously identified as Sabin PV-1, 2 and 3 respectively), primer AN89 (Nix 
PV-3, CV-A13 (S/N 11), E3 (S/N 1) E7 (S/N 3), in sample 14 has an Asparagine (N) at the same position. The Sabin-3 primer also produced the PV-1 and confirmed by primers AN89 and the SRPs as such, also contained PV-2 and PV-3 ( Table   2 4 3 1).
4 4
For sample 16 which contained four EV-Cs (PV-1, PV-2, PV-3 and CV-A13), and two EV-Bs (E3 showed that while the amplicon from primer 189 produced unexploitable sequence data, primers 2 4 7 AN89, 187, Sab-1, Sab-2 and Sab-3 detected PV-2, PV-1, PV-1, PV-2 and PV-3, respectively 2 4 8 (Table 1) . Otherwise stated, AN89 and the SRPs (primers 189 and 187) only detected PV-2 and 2 4 9
PV-1 respectively from the mixture while the PRPs specifically detected all the three poliovirus 2 5 0 serotypes. Importantly, the PV-2 and 3 detected in sample 16 were exactly those found in samples 2 5 1 14 and 15 respectively (Table 1) . 
